全文获取类型
收费全文 | 6296篇 |
免费 | 566篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 110篇 |
妇产科学 | 297篇 |
基础医学 | 736篇 |
口腔科学 | 140篇 |
临床医学 | 697篇 |
内科学 | 1401篇 |
皮肤病学 | 76篇 |
神经病学 | 611篇 |
特种医学 | 403篇 |
外科学 | 701篇 |
综合类 | 131篇 |
一般理论 | 2篇 |
预防医学 | 369篇 |
眼科学 | 167篇 |
药学 | 363篇 |
2篇 | |
中国医学 | 64篇 |
肿瘤学 | 597篇 |
出版年
2023年 | 32篇 |
2021年 | 135篇 |
2020年 | 84篇 |
2019年 | 182篇 |
2018年 | 207篇 |
2017年 | 167篇 |
2016年 | 188篇 |
2015年 | 239篇 |
2014年 | 276篇 |
2013年 | 338篇 |
2012年 | 441篇 |
2011年 | 471篇 |
2010年 | 304篇 |
2009年 | 288篇 |
2008年 | 330篇 |
2007年 | 309篇 |
2006年 | 361篇 |
2005年 | 271篇 |
2004年 | 269篇 |
2003年 | 240篇 |
2002年 | 207篇 |
2001年 | 160篇 |
2000年 | 146篇 |
1999年 | 120篇 |
1998年 | 71篇 |
1997年 | 66篇 |
1996年 | 53篇 |
1995年 | 32篇 |
1994年 | 40篇 |
1993年 | 37篇 |
1992年 | 77篇 |
1991年 | 74篇 |
1990年 | 58篇 |
1989年 | 76篇 |
1988年 | 48篇 |
1987年 | 43篇 |
1986年 | 54篇 |
1985年 | 40篇 |
1984年 | 34篇 |
1983年 | 38篇 |
1982年 | 31篇 |
1981年 | 28篇 |
1980年 | 16篇 |
1979年 | 21篇 |
1978年 | 21篇 |
1977年 | 18篇 |
1975年 | 19篇 |
1974年 | 30篇 |
1973年 | 21篇 |
1972年 | 18篇 |
排序方式: 共有6914条查询结果,搜索用时 15 毫秒
1.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
2.
3.
4.
5.
6.
TF Leung WC Tsoi CK Li KW Chik MMK Shing PMP Yuen 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(6):705-777
We describe a 15-y-old girl with Fechtner-like syndrome, who is the first Chinese reported to have this rare syndrome. She presented with left homonymous hemianopia and neuroimaging revealed haemorrhage in both parietal and occipital lobes. Peripheral blood smear showed macrothrombocytopenia and intracytoplasmic inclusion bodies inside leucocytes. Thrombocytopenia and proteinuria responded to intravenous immunoglobulin and pulsed methylprednisolone. This case illustrates that life-threatening haemorrhage can occur in patients with Fechtner syndrome. Although there was no effective treatment reported in the literature, high dose steroid and immunoglobulin seemed to be useful in our patient. Our patient also had nephritic-nephrotic syndrome with renal insufficiency, which is unusual in adolescent female patients. 相似文献
7.
Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma 总被引:9,自引:3,他引:6
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
8.
Nonsurgical management of partial adhesive small-bowel obstruction with oral therapy: a randomized controlled trial 总被引:2,自引:0,他引:2 下载免费PDF全文
9.
Feng-Yuan Liu Chien-Yu Lin Joseph T Chang Shu-Hang Ng Shy-Chyi Chin Hung-Ming Wang Chun-Ta Liao Sheng-Chieh Chan Tzu-Chen Yen 《Journal of nuclear medicine》2007,48(10):1614-1619
Conventional work-up (CWU) with chest radiography, abdominal ultrasonography, and skeletal scintigraphy has limited value in M staging of nonkeratinizing nasopharyngeal carcinoma (NPC). Our aim was to evaluate whether (18)F-FDG PET could replace CWU by comparing their diagnostic efficacies. METHODS: Patients with histologically proven nonkeratinizing NPC and no prior treatment were prospectively enrolled. All study participants underwent CWU and (18)F-FDG PET for primary M staging. Distant metastasis was considered to be present if there was any reliable evidence identified within 1 y after diagnosis. The comparative diagnostic efficacies of (18)F-FDG PET, CWU, and the combination of (18)F-FDG PET and CWU (PET+CWU) were evaluated using the areas under the receiver-operating-characteristic (ROC) curves. RESULTS: Sixty-one (20.3%) of 300 eligible patients were found to have distant metastases. On a patient-based analysis, (18)F-FDG PET was found to be more effective than CWU (P < 0.001), whereas it was equally effective with PET+CWU (P = 0.130). On region-based analyses, (18)F-FDG PET was more effective than skeletal scintigraphy and chest radiography for detecting bone metastases (P < 0.001) and chest metastases (P < 0.001), respectively. (18)F-FDG PET and abdominal ultrasound were equally effective for detecting hepatic metastases (P = 0.127). On region-based analyses, the combination of (18)F-FDG PET and CWU did not yield any noticeable increase in diagnostic efficacy. CONCLUSION: (18)F-FDG PET can replace CWU in primary M staging of nonkeratinizing NPC. 相似文献
10.